AU2002330801A1 - Method for oral transmucosal delivery of interferon - Google Patents

Method for oral transmucosal delivery of interferon

Info

Publication number
AU2002330801A1
AU2002330801A1 AU2002330801A AU2002330801A AU2002330801A1 AU 2002330801 A1 AU2002330801 A1 AU 2002330801A1 AU 2002330801 A AU2002330801 A AU 2002330801A AU 2002330801 A AU2002330801 A AU 2002330801A AU 2002330801 A1 AU2002330801 A1 AU 2002330801A1
Authority
AU
Australia
Prior art keywords
interferon
transmucosal delivery
oral transmucosal
oral
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002330801A
Inventor
Igor Anatolievich Pomytkin
Evgeny Nikolaevich Sventytsky
Yuriy Vasilievich Tyagotin
Pavel Vasilievich Veteletsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002330801A1 publication Critical patent/AU2002330801A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002330801A 2002-06-20 2002-06-20 Method for oral transmucosal delivery of interferon Abandoned AU2002330801A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2002/000300 WO2004000266A1 (en) 2002-06-20 2002-06-20 Method for oral transmucosal delivery of interferon

Publications (1)

Publication Number Publication Date
AU2002330801A1 true AU2002330801A1 (en) 2004-01-06

Family

ID=29997637

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002330801A Abandoned AU2002330801A1 (en) 2002-06-20 2002-06-20 Method for oral transmucosal delivery of interferon

Country Status (2)

Country Link
AU (1) AU2002330801A1 (en)
WO (1) WO2004000266A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040258663A1 (en) * 2003-05-08 2004-12-23 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of interferon alpha
WO2016169571A1 (en) * 2015-04-20 2016-10-27 Ghaleb Haider Abbas Pharmaceutical product for treatment & prophylaxis of viral/ microbial infection
EP3801599A1 (en) * 2018-06-01 2021-04-14 ILC Therapeutics Ltd Compositions and methods relating to the treatment of diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017371A (en) * 1988-01-06 1991-05-21 Amarillo Cell Culture Company, Incorporated Method for reducing side effects of cancer therapy
MX9102512A (en) * 1990-12-14 1992-06-01 Schering Corp ORAL ADMINISTRATION OF ALPHA INTERFERON IN THE TREATMENT OF LUNG DISEASES.
WO1997025862A1 (en) * 1996-01-19 1997-07-24 Mcgill University Hepatitis pretreatment composition and method
US20010043906A1 (en) * 1999-12-30 2001-11-22 Vlasselaer Peter Van gamma-IFN liquid-droplet aerosol and method

Also Published As

Publication number Publication date
WO2004000266A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
AU2002319653A1 (en) Method for oral drug delivery
AU2003284115A1 (en) Method of delivering local anesthesia
AU2003209475A1 (en) Fast melt multiparticulate formulations for oral delivery
AU2003280373A1 (en) Method of administering bisphosphonates
IL165172A0 (en) Compositions and method for enhanced mucosal delivery of interfern beta
AU2003299849A1 (en) Drug delivery apparatus
AU2003211376A1 (en) Drug administration method
EP1478345A4 (en) Novel pharmaceutical dosage forms and method for producing same
EP1383518A4 (en) Oral delivery of macromolecules
AU2003284387A1 (en) Delivery composition and method
IL166337A0 (en) Oral administration of calctionin
AU2003277596A1 (en) Method of deuterization
AU2003290436A1 (en) Oral preparation system
AU2003276688A1 (en) Pharmaceutical composition of metaxalone with enhanced oral bioavailability
AU2002330801A1 (en) Method for oral transmucosal delivery of interferon
AU2002308649A1 (en) Compositions and methods for enhancing drug delivery
WO2003067458A8 (en) Parts ordering system for improving efficiency of parts delivery
AU2003284786A1 (en) Microemulsion composition for oral administration of biphenyldimethyldicarboxylate
AU2003302185A1 (en) Orthodontic wire and method for making same
AU2003289462A1 (en) Method for producing ceramic structure
AU2003263384A1 (en) Orthodontic apparatus
AU2003236892A1 (en) Dental elevator
AU2003244092A1 (en) 1ss-METHYLCARBAPENEM DERIVATIVE FOR ORAL ADMINISTRATION
PL372298A1 (en) Method for producing interferon
AU2003266612A1 (en) Method of measuring glycoprotein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase